David Shapiro

CIK 1559570 · Chief Medical Officer · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

82

Lifetime Open-Market Net

-$32.90M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
DSGN Director $10.97 $0 2 2026-06-11
Damora Therapeutics, Inc. (GLTO) Delisted Director $28.69 $0 4 2025-06-20
VivoSim Labs, INC. (ONVO) Delisted Director $2.04 $0 2 2019-09-09
INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Chief Medical Officer 41,499 $19.00 $788.5K -$32.90M 74 2019-05-03

Recent Filings · Page 8 of 9

82 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2014-01-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Exer (M) +1,623 $0 EDGAR
2013-12-17 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed −1,266 -$272.5K EDGAR
2013-11-19 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed −980 -$188.4K EDGAR
2013-10-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed +980 -$280.7K EDGAR
2013-09-18 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed −1,266 -$207.8K EDGAR
2013-08-16 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed −1,004 -$175.1K EDGAR
2013-07-03 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed +1,004 -$151.6K EDGAR
2013-06-19 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed −1,266 -$125.1K EDGAR
2013-05-20 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Mixed −1,266 -$118.0K EDGAR
2013-05-09 INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted Grant (A) +3,000 $0 EDGAR
Showing 7180 of 82
Page 8 of 9
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.